News & Updates
Excerpt from the Article: Identifying these easily missed breaks can save patients from future negative complications or loss of function. A significant number of the most common type of wrist fracture go undetected on X-ray images, setting patients up for potential problems downstream. But, a new artificial intelligence (AI)-based automated system can improve detection rates.…
Read More
Excerpt from the Article: Moderna, one of three companies to have a COVID-19 vaccine authorized in the U.S., isn’t resting on its accomplishments but is instead working to scale up production further and improve on its vaccine. One of the downsides of the vaccine initially was its cold-storage requirements. It is approved for storage at between 36…
Read More
Excerpt from the Press Release: PHILADELPHIA, April 20, 2021 /PRNewswire/ — A trans-Atlantic collaborative group of researchers led by Children’s Hospital of Philadelphia (CHOP) has received approximately $680,000 from a group of research charities led by Solving Kids’ Cancer UK to study slowly progressive, or “indolent,” neuroblastoma, which does not respond to chemotherapy and lacks other treatment options. The grant will fund…
Read More
Excerpt from the Press Release: EMERYVILLE, Calif., April 21, 2021 /PRNewswire/ — DYNAVAX TECHNOLOGIES CORPORATION (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced Valneva SE has initiated a pivotal Phase 3 clinical trial for its inactivated, COVID-19 vaccine candidate, VLA2001, using Dynavax’s CpG 1018 adjuvant. The Phase 3 trial “Cov-Compare”, (VLA2001-301), will compare Valneva’s SARS-CoV-2 vaccine candidate, VLA2001, against…
Read More
Clinical Trials Ontario has released a Clinical Trial Restart Toolkit! “This toolkit provides a collection of best practices, considerations, and resources for clinical trial conduct in the face of the COVID-19 pandemic. The aim of this toolkit is to provide guidance for sites and sponsors that are looking to restart clinical trials during a pandemic.…
Read More
Excerpt from the Press Release: CAMBRIDGE, Mass., April 20, 2021 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, today presented full clinical data from the Phase 1b clinical trial cohort evaluating EDP1815 for the treatment of mild and moderate atopic dermatitis in a…
Read More
Excerpt from the Article: COVID-19 vaccines have quickly come to the rescue. Scientists created a vaccine to prevent the new virus using foundational research and technology developed at Penn. Today, as we race to vaccinate more people in more places against COVID-19, the biology behind these vaccines is poised to change the world again: With…
Read More
Excerpt from the Press Release: REDWOOD CITY, Calif., April 21, 2021 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused on developing targeted therapies to inhibit frontier targets in RAS-addicted cancers, today announced dosing of the first patient in a multicenter Phase 1/1b clinical trial evaluating RMC-5552, the company’s investigational…
Read More
Excerpt from the Press Release: NEWTOWN, Pa., April 22, 2021 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, announced today that the first patient has been dosed in an investigator-initiated Phase 2 study to assess the efficacy and safety of rigosertib…
Read More
Excerpt from the Press Release: MALVERN, Pa., April 21, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that its co-development partner, Bharat Biotech, shared positive results of the second interim analysis…
Read MoreRequest Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?